Istituto di Scienze della Vita, Scuola Superiore Sant'Anna, Pisa, Italy; Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
Istituto di Scienze della Vita, Scuola Superiore Sant'Anna, Pisa, Italy.
Int J Cardiol. 2021 Sep 15;339:62-69. doi: 10.1016/j.ijcard.2021.07.036. Epub 2021 Jul 24.
The epidemiology, clinical features and outcome of myocardial infarction (MI) display significant differences between men and women. Prominent sex differences have also been suggested in left ventricular (LV) remodeling after MI. Ventricular remodeling refers to a deterioration of LV geometry and function often leading to heart failure (HF) development and an increased risk of adverse cardiovascular events. Women have a lower propensity to the acquisition of a spherical geometry and LV dysfunction. These differences can be attributed at least partially to a lower frequency of transmural infarction and smaller areas of microvascular obstruction in women, as well as to a less prominent activation of neuroendocrine systems and apoptotic, inflammatory and profibrotic pathways in women. Estrogens might play a role in this difference, which could partially persist even after the menopause because of a persisting intramyocardial synthesis of estrogens in women. Conversely, androgens may exert a detrimental influence. Future studies should better clarify sex differences in the predictors, clinical correlates, prognostic impact and disease mechanisms of remodeling, as well as the existence of sex-specific therapeutic targets. This research effort should hopefully allow to optimize the treatment of MI during the acute and post-acute phase, possibly through different therapeutic strategies in men and women, with the goal of reducing the risk of HF development and improving patient outcome.
心肌梗死(MI)的流行病学、临床特征和结局在男性和女性之间存在显著差异。MI 后左心室(LV)重构也表现出明显的性别差异。心室重构是指 LV 几何形状和功能的恶化,常导致心力衰竭(HF)的发生和不良心血管事件风险的增加。女性发生球形几何形状和 LV 功能障碍的倾向较低。这些差异至少部分归因于女性透壁性梗死的频率较低,微血管阻塞的面积较小,以及女性神经内分泌系统、细胞凋亡、炎症和纤维化途径的激活不那么明显。雌激素可能在这种差异中起作用,即使在绝经后,由于女性心肌内雌激素的持续合成,这种差异仍可能部分存在。相反,雄激素可能产生有害影响。未来的研究应更好地阐明重构的预测因素、临床相关性、预后影响和疾病机制中的性别差异,以及是否存在特定于性别的治疗靶点。这一研究工作有望通过男性和女性不同的治疗策略,优化 MI 在急性期和亚急性期的治疗,从而降低 HF 发生的风险,改善患者的预后。